DE2343517A1 - Neues zns-aktives praeparat - Google Patents

Neues zns-aktives praeparat

Info

Publication number
DE2343517A1
DE2343517A1 DE19732343517 DE2343517A DE2343517A1 DE 2343517 A1 DE2343517 A1 DE 2343517A1 DE 19732343517 DE19732343517 DE 19732343517 DE 2343517 A DE2343517 A DE 2343517A DE 2343517 A1 DE2343517 A1 DE 2343517A1
Authority
DE
Germany
Prior art keywords
active ingredient
pharmaceutical according
pharmaceutical
dosage unit
per dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19732343517
Other languages
German (de)
English (en)
Inventor
Alberto Rossi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1284272A external-priority patent/CH554336A/xx
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of DE2343517A1 publication Critical patent/DE2343517A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DE19732343517 1972-08-31 1973-08-29 Neues zns-aktives praeparat Pending DE2343517A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1284272A CH554336A (de) 1972-08-31 1972-08-31 Verfahren zur herstellung eines neuen alkohols.
CH941873 1973-06-28

Publications (1)

Publication Number Publication Date
DE2343517A1 true DE2343517A1 (de) 1974-03-07

Family

ID=25704785

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19732343517 Pending DE2343517A1 (de) 1972-08-31 1973-08-29 Neues zns-aktives praeparat

Country Status (5)

Country Link
AU (1) AU5975573A (ja)
DE (1) DE2343517A1 (ja)
FR (1) FR2197588A1 (ja)
IL (1) IL43028A0 (ja)
NL (1) NL7311960A (ja)

Also Published As

Publication number Publication date
NL7311960A (ja) 1974-03-04
AU5975573A (en) 1975-03-06
FR2197588A1 (en) 1974-03-29
IL43028A0 (en) 1973-11-28

Similar Documents

Publication Publication Date Title
DE69930243T2 (de) Behandlung iatrogenen und altersbedingten bluthochdruck mit vitamin b6-derivative, und pharmazeutische zusammensetzungen verwendbar dazu
DE1802394C2 (de) Arzneimittel mit antihypertensiver Wirkung, die [(2,6-Dichlorbenzyliden)-amino]-guanidin oder ein Säureadditionssalz davon enthalten
EP0185210B1 (de) Verwendung von Dipeptidderivaten für die Herstellung von Arzneimitteln zur Behandlung von an amyotropher Lateralsklerose Erkrankten
DE3343934A1 (de) M-chlor-(alpha)-tert.-butylaminopropiophenon und seine verwendung zur senkung des cholesterolspiegels
EP0224810B1 (de) Antihypertensives Kombinationspräparat
DE3419935A1 (de) Verwendung von hydroxyindolderivaten bei der senkung des blutdrucks
DE2362123A1 (de) Pharmazeutische zubereitungen
DE1900772C3 (de) Salz aus N,N-Dimethylbiguanid und p-Chlorphenoxyessigsäure sowie dieses enthaltende Arzneimittel
EP0206297B1 (de) 4-Amino-2-(imidazolidin-2-on-l-yl)-pyrimidin-5-carbonsäure-(N-(3-trifluormethyl-phenyl)-amide) zur antithrombotischen Prophylaxe und Behandlung sowie ihre Verwendung zur Herstellung von antithrombotisch wirksamen Arzneimitteln
DE2528460A1 (de) Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans
DE2416339C3 (de) Argininpyroglutaniat, Verfahren zu seiner Herstellung und Arzneimittel
DE2343517A1 (de) Neues zns-aktives praeparat
DE69919789T2 (de) Loratadin zur Verwendung als Antiarrhythmikum
DE2343637A1 (de) Neues zns-aktives praeparat
DE3904795C2 (de) Pharmazeutisches Präparat und dessen Verwendung
DE69909395T2 (de) Zusammensetzung mit ketanserin und carnitin zur behandlung von crps
DE2001158A1 (de) Neues schmerzstillendes Praeparat
DE2131626A1 (de) 3,4,5-Dialkoxy-hydroxybenzoylaminoalkancarbonsaeuren und ihre Salze sowie Arzneipraeparate
EP0442141B1 (de) Pharmazeutische Zubereitung
DE1792271C3 (de) Blutdrucksenkendes Arzneimittel
EP0281608A1 (de) Hydroxyindolderivat.
DE2342214A1 (de) Heilmittel
DE2615694A1 (de) Pharmazeutische zusammensetzungen
DE2636328A1 (de) Arzneimittel
DE2532180C2 (de) Verwendung von Etozolin bei der Bekämpfung der Hypertonie